Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
Each year Mitchell celebrates one of its partners through the "mPower Award" highlighting innovative and transformational initiatives taken on in t
On this episode of Mitchell’s mPower podcast series, Product Management Director Chris Williamson joins our host, Shelley Callahan, senior director
The stories Natasha Charleston heard were haunting.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Just two years ago, some experts predicted the
The quarterly LOR summary is produced by